Clinical Trial
A double-blind controlled study of the use of diethylpropion hydrochloride (Tenuate) in obese patients in a rural practice
- PMID: 282482
Item in Clipboard
Clinical Trial
A double-blind controlled study of the use of diethylpropion hydrochloride (Tenuate) in obese patients in a rural practice
N Z Med J.
.
Abstract
A double-blind, placebo-controlled, cross-over study has been carried out to compare long-acting diethylpropion hydrochloride (Tenuate Dospan, Wm. S. Merrell Company, hereafter referred to as TD) in a rural general practice. TD was found to produce significantly more weight loss than placebo and side effects were not significantly greater. The need for the treatment of obese patients in general practice is discussed, as is the role of anorexiant therapy.
Similar articles
-
Double blind evaluation of long acting diethylpropion hydrochloride in obese patients from a general practice.Med J Aust. 1975 Jan 4;1(1):13-5. Med J Aust. 1975. PMID: 1092973 Clinical Trial.
-
Controlled-release diethylpropion hydrochloride used in a program for weight reduction.Clin Ther. 1981;3(5):329-35. Clin Ther. 1981. PMID: 7471128
-
Diethylpropion hydrochloride (Tenuate Dospan) in combination with hypotensive agents in the treatment of obesity associated with hypertension.Curr Ther Res Clin Exp. 1974 May;16(5):398-413. Curr Ther Res Clin Exp. 1974. PMID: 4209056 No abstract available.
-
[Weight reduction in obese diabetics: a double-blind study of diethylpropionate (author's transl)].Wien Klin Wochenschr. 1979 Jun 22;91(13):455-8. Wien Klin Wochenschr. 1979. PMID: 380178 Clinical Trial. German.
-
Diethylpropion.2018 Jan 3. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2018 Jan 3. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644094 Free Books & Documents. Review.
Cited by
-
Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients.Clinics (Sao Paulo). 2017 May;72(5):317-324. doi: 10.6061/clinics/2017(05)10. Clinics (Sao Paulo). 2017. PMID: 28591345 Free PMC article.